---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-235410"
form_type: "8-K"
ticker: "BLCO"
cik: "0001860742"
company_name: "Bausch & Lomb Corp"
filed_at: "2023-09-14T23:59:59+00:00"
generated_at: "2026-06-10T17:55:28.203590+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bausch + Lomb prices $1.4B 8.375% senior secured notes due 2028 for XIIDRA acquisition financing

## Summary
- Priced $1.4B aggregate principal of 8.375% senior secured notes due 2028 at par; closing expected Sept 29, 2023.
- Also plans $500M incremental term B loans under existing credit facility; drawn upon acquisition close.
- Net proceeds to fund pending acquisition of XIIDRA (lifitegrast ophthalmic solution) and other ophthalmology assets.
- If notes issued before acquisition close, proceeds held in escrow by Bausch + Lomb Escrow Corp.; B+L assumes after close.
- If acquisition not closed by Sept 30, 2024, Escrow Issuer must redeem notes at principal plus accrued interest.

## SEC filing metadata
- accession: 0001193125-23-235410
- form_type: 8-K
- ticker: BLCO
- cik: 0001860742
- company_name: Bausch & Lomb Corp
- filed_at: 2023-09-14T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860742/000119312523235410/0001193125-23-235410-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860742/000119312523235410/d507757d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-235410
- JSON: https://secwatch.observer/filing/0001193125-23-235410.json
- Plain text: https://secwatch.observer/filing/0001193125-23-235410.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.